MOHAMED COULIBALY DIT FALL: Open Payments
NPI 1255745840 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 12 payments from 6 companies in 2025. Trend: 2023 $123 · 2024 $122 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $156 |
| ABBVIE INC. | 3 | $69 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Boston Scientific Corporation | 1 | $26 |
| Cranial Technologies, Inc | 2 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: Ozempic, VRAYLAR, TRINTELLIX, WATCHMAN FLX, Doc Band, GVOKE HYPOPEN.
Industry payments across AZ — which companies pay providers there.
